Youming Li

5.2k total citations · 1 hit paper
111 papers, 3.9k citations indexed

About

Youming Li is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Youming Li has authored 111 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Epidemiology, 24 papers in Molecular Biology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Youming Li's work include Liver Disease Diagnosis and Treatment (64 papers), Alcohol Consumption and Health Effects (17 papers) and Diet, Metabolism, and Disease (16 papers). Youming Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (64 papers), Alcohol Consumption and Health Effects (17 papers) and Diet, Metabolism, and Disease (16 papers). Youming Li collaborates with scholars based in China, United States and Germany. Youming Li's co-authors include Chaohui Yu, Chengfu Xu, Lei Xu, Xingyong Wan, Xi Jin, Min Miao, Shaohua Chen, Yiming Lin, Weixing Chen and Yipeng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Youming Li

108 papers receiving 3.8k citations

Hit Papers

The associations between modifiable risk factors and nona... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youming Li China 34 2.2k 1.2k 719 699 662 111 3.9k
Senthil Kumar Venugopal India 26 1.4k 0.6× 1.0k 0.8× 541 0.8× 364 0.5× 123 0.2× 58 3.5k
Qiaobing Huang China 37 759 0.3× 1.8k 1.5× 398 0.6× 174 0.2× 262 0.4× 142 4.1k
Mingxiang Zhang China 34 906 0.4× 1.8k 1.5× 511 0.7× 320 0.5× 162 0.2× 120 4.3k
Stefano Menini Italy 41 581 0.3× 1.3k 1.0× 292 0.4× 812 1.2× 214 0.3× 72 4.0k
Martin Bischof Austria 29 869 0.4× 617 0.5× 128 0.2× 737 1.1× 507 0.8× 61 2.8k
Antonios Chatzigeorgiou Greece 32 1.1k 0.5× 712 0.6× 202 0.3× 523 0.7× 168 0.3× 93 3.1k
Melania Gaggini Italy 28 2.2k 1.0× 1.2k 0.9× 211 0.3× 1.3k 1.8× 275 0.4× 83 3.9k
Terry D. Hinds United States 39 1.1k 0.5× 2.3k 1.8× 182 0.3× 771 1.1× 379 0.6× 94 3.9k
Yoshimasa Aso Japan 35 1.5k 0.7× 1.0k 0.8× 167 0.2× 1.6k 2.3× 192 0.3× 160 4.3k
Giulio Ceolotto Italy 33 461 0.2× 1.3k 1.0× 308 0.4× 736 1.1× 139 0.2× 105 3.2k

Countries citing papers authored by Youming Li

Since Specialization
Citations

This map shows the geographic impact of Youming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youming Li more than expected).

Fields of papers citing papers by Youming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youming Li. The network helps show where Youming Li may publish in the future.

Co-authorship network of co-authors of Youming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Youming Li. A scholar is included among the top collaborators of Youming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youming Li. Youming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yanjun, Shenghui Chen, Zhening Liu, et al.. (2025). Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation. Experimental & Molecular Medicine. 57(5). 990–1004.
2.
Xie, Jiarong, Linxiao Hou, Min Miao, et al.. (2024). Risk of incident type 2 diabetes in male NAFLD and NAFLD-free smokers: a 7-year post-cessation study. Diabetology & Metabolic Syndrome. 16(1). 192–192. 1 indexed citations
3.
Xie, Jiarong, Lei Xu, Hangkai Huang, et al.. (2023). A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study. Hepatology International. 17(5). 1182–1191. 4 indexed citations
4.
Li, Meng, Xin Song, Yishu Chen, et al.. (2022). 3‐Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma. Liver International. 42(5). 1173–1184. 11 indexed citations
5.
Jin, Xi, Jianguo Gao, Ruoheng Zheng, et al.. (2020). Antagonizing circRNA_002581–miR-122–CPEB1 axis alleviates NASH through restoring PTEN–AMPK–mTOR pathway regulated autophagy. Cell Death and Disease. 11(2). 123–123. 88 indexed citations
6.
Hong, Yun, Sirui Li, Jifeng Wang, & Youming Li. (2018). In vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A. Scientific Reports. 8(1). 9232–9232. 39 indexed citations
7.
Jin, Xi, Jiang Liu, Yipeng Chen, et al.. (2017). Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis. PLoS ONE. 12(3). e0174218–e0174218. 11 indexed citations
9.
Shen, Zhe, Stefan Munker, Boyan Zhou, et al.. (2016). The Accuracies of Diagnosing Pancreas Divisum by Magnetic Resonance Cholangiopancreatography and Endoscopic Ultrasound: A Systematic Review and Meta-analysis. Scientific Reports. 6(1). 35389–35389. 20 indexed citations
10.
Wang, Jinghua, Chengfu Xu, Yunhao Xun, et al.. (2015). ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Scientific Reports. 5(1). 16494–16494. 106 indexed citations
11.
Chen, Dongya, et al.. (2014). [The clinical characteristics of 32 patients with autoimmune pancreatitis].. PubMed. 53(5). 380–3.
13.
Li, Lan, Guogang Li, Chaohui Yu, & Youming Li. (2013). A meta-analysis of the role of p38 mitogen-activated protein kinase inhibitors in patients with active rheumatoid arthritis. Clinical Rheumatology. 32(12). 1697–1702. 5 indexed citations
14.
Chen, Shaohua, Weixing Chen, & Youming Li. (2012). Clinical analysis of 50 cases of hepatic veno-occlusive disease. Zhonghua xiaohua zazhi. 32(9). 620–624. 5 indexed citations
15.
Wu, Yijun, Qi Li, Xinhui Zhou, et al.. (2012). Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer. PLoS ONE. 7(4). e35684–e35684. 25 indexed citations
16.
Fang, Youhong, et al.. (2009). Takayasu’s arteritis associated with Crohn’s disease. Journal of Zhejiang University SCIENCE B. 10(8). 631–634. 8 indexed citations
17.
Yu, Chaohui, Chengfu Xu, & Youming Li. (2008). Association of MicroRNA-223 Expression with Hepatic Ischemia/Reperfusion Injury in Mice. Digestive Diseases and Sciences. 54(11). 2362–2366. 67 indexed citations
18.
Jin, Xi, Ruoheng Zheng, & Youming Li. (2008). Green tea consumption and liver disease: a systematic review. Liver International. 28(7). 990–996. 57 indexed citations
19.
Chen, Weixing, et al.. (2006). Clinical manifestations of patients with chronic pancreatitis.. PubMed. 5(1). 133–7. 9 indexed citations
20.
Chen, Weixing, Youming Li, Chaohui Yu, et al.. (2002). Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World Journal of Gastroenterology. 8(2). 379–379. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026